Literature DB >> 11327616

One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit?

S Padberg1, K Heller, K H Usadel, P M Schumm-Draeger.   

Abstract

Studies in animal models of spontaneous Hashimoto's autoimmune thyroiditis (HT) show that prophylactic treatment with levothyroxine (LT4) can reduce incidence and degree of lymphocytic infiltration in HT. The aim of the present study was to clarify whether there is a benefit of prophylactic treatment with LT4 in patients with euthyroid HT with respect to the progression of the autoimmune process. Twenty-one patients with euthyroid HT were checked for thyroid function (thyrotropin [TSH], free triiodothyronine [FT3], free thyroxine [FT4]), thyroid volume, antibodies (thyroglobulin [Tg-Ab], thyroid peroxidase [TPO-Ab]), and lymphocyte subsets. Peripheral (PBL) and thyroid-derived lymphocytes (TL) were analyzed by triple color flow cytometry. One-half of the patients with euthyroid HT were treated with LT4 for 1 year (n = 10). The other half (n = 11) were never treated with LT4. TL were obtained by fine-needle aspiration biopsy (FNAB). Thirteen healthy subjects (C) without medical history of thyroid disease served as controls concerning PBL, and patients with non-toxic nodular goiter (NG; n = 10) served as controls concerning TL. Thyroid-derived T-helper cells were found more frequently in euthyroid patients with HT compared to patients with NG (p < 0.01). After 1 year of therapy with LT4, TPO-Abs and B lymphocytes decreased significantly only in the treated group of euthyroid patients with HT (p < 0.05). In contrast, TPO-Abs levels did not change or even increased in untreated euthyroid patients with HT. Thyroid volume did not differ before and after therapy. Prophylactic treatment of euthyroid patients with HT reduced both serological and cellular markers of autoimmune thyroiditis. Therefore, prophylactic LT4 treatment might be useful to stop the progression or even manifestation of the disease. However, the long-term clinical benefit of prophylactic LT4 therapy in euthyroid patients with HT is yet to be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327616     DOI: 10.1089/105072501750159651

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  19 in total

Review 1.  Thyroid autoimmunity and pre-term delivery: brief review and meta-analysis.

Authors:  R Negro
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 2.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

3.  A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes.

Authors:  C R de Farias; B R Cardoso; G M B de Oliveira; I C de Mello Guazzelli; R M Catarino; M C Chammas; S M F Cozzolino; M Knobel
Journal:  J Endocrinol Invest       Date:  2015-04-17       Impact factor: 4.256

4.  Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial.

Authors:  Danilo B Höfling; Maria Cristina Chavantes; Adriana G Juliano; Giovanni G Cerri; Meyer Knobel; Elisabeth M Yoshimura; Maria Cristina Chammas
Journal:  Lasers Med Sci       Date:  2012-06-21       Impact factor: 3.161

5.  Long-term Observation of Thyroid Volume Changes in Hashimoto's Thyroiditis in a Series of Women on or off Levo-Thyroxine Treatment in an Area of Moderate Iodine Sufficiency.

Authors:  M Giusti; M Sidoti
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

6.  [Autoimmune thyroiditis. Treatment with thyroid gland hormones in subclinical hypothyroidism or already in euthyroid state?].

Authors:  K H Usadel; P M Schumm-Draeger
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

7.  Long-term outcome of hormonal status in Taiwanese children with Hashimoto's thyroiditis.

Authors:  Shuo-Yu Wang; Yi-Ching Tung; Wen-Yu Tsai; Jing-Sheng Lee; Pei-Hung Hsiao
Journal:  Eur J Pediatr       Date:  2006-03-24       Impact factor: 3.183

8.  Sequential elevation of autoantibodies to thyroglobulin and glutamic acid decarboxylase in type 1 diabetes.

Authors:  Eiji Kawasaki; Jun-Ichi Yasui; Masako Tsurumaru; Haruko Takashima; Toshiyuki Ikeoka; Fumi Mori; Satoru Akazawa; Ikuko Ueki; Masakazu Kobayashi; Hironaga Kuwahara; Norio Abiru; Hironori Yamasaki; Atsushi Kawakami
Journal:  World J Diabetes       Date:  2013-10-15

9.  Clinical course of Hashimoto's thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents.

Authors:  Samim Özen; Ömer Berk; Damla Gökşen Şimşek; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

10.  Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus.

Authors:  Kostas Kakleas; Evangelia Paschali; Nikos Kefalas; Aspasia Fotinou; Maria Kanariou; Christina Karayianni; Kyriaki Karavanaki
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.